Cargando…

Epidemiological and clinical characteristics of SARS-CoV-2 reinfections in a Spanish region

OBJECTIVE: We aimed to assess the prevalence and clinical characteristics of SARS-CoV-2 reinfections in a Spanish region. METHODS: This is a retrospective observational study in all patients with SARS-CoV-2 infections in the Lleida health region from 1 March to 30 November 2020. Reinfections were cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuguero, Oriol, Companys, Maria, Guzmán, Marianela, Maciel, Rita, Llobet, Cecília, López, Aurora, Olles, Rebeca, Pujol, Violant, Ruiz, Maria José, Saura, Mireia, Vidal, Carmel, Godoy, Pere
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244920/
https://www.ncbi.nlm.nih.gov/pubmed/35784672
http://dx.doi.org/10.1177/20503121221108556
Descripción
Sumario:OBJECTIVE: We aimed to assess the prevalence and clinical characteristics of SARS-CoV-2 reinfections in a Spanish region. METHODS: This is a retrospective observational study in all patients with SARS-CoV-2 infections in the Lleida health region from 1 March to 30 November 2020. Reinfections were classified as patients with positive SARS-CoV-2 PCR tests separated by at least 90 days plus a negative test result between both infection episodes. Primary and secondary outcomes: The primary outcome was the percentage of SARS-CoV-2 reinfections among all SARS-CoV-2 infections detected during our study period. Secondary outcomes were the clinical and sociodemographic characteristics of patients with SARS-CoV-2 reinfections. RESULTS: Of the 27,758 patients diagnosed with SARS-CoV-2 infection in the study period, 14 were identified as coronavirus reinfection (0.050%). Of the reinfected sample, 12 patients (85.7%) were women. The median age was 41.5 years. Two patients died in the second coronavirus episode. CONCLUSION: The reinfection rate of SARS-CoV-2 in the Spanish region Lleida was relatively low during the observational period in 2020 (less than 1%). These data are in line with the notion that previous SARS-CoV-2 infections may offer a significant protection by so called natural immunity.